Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study
Carla Casulo(University of Rochester Medical Center), Matthew J. Maurer(Mayo Clinic in Arizona), Jonathon B. Cohen(Emory University), Thomas M. Habermann(Mayo Clinic in Arizona), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Peter Martin(Northwestern University), Julianne J. Lunde(Mayo Clinic in Florida), Anthony Masaquel, Izidore S. Lossos(University of Miami), Dai Chihara(The University of Texas MD Anderson Cancer Center), Ashwini Shewade, Michael C. Wei(The Royal Melbourne Hospital), Brad S. Kahl(UW Health University Hospital), James R. Cerhan(Mayo Clinic), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Brian K. Link(University of Iowa), Jean L. Koff(Emory University), Jia Li(Zhejiang Wanli University), Mei Wu(Nanfang Hospital), Yucai Wang(Mayo Clinic), Melissa C. Larson(Mayo Clinic), Christopher Strouse(University of Iowa Hospitals and Clinics), Yong Mun, Richard Burack(University of Rochester Medical Center)
Cited by 65
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k